![John W. Gillard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John W. Gillard
Directeur Technique/Scientifique/R&D chez Aegera Therapeutics, Inc.
Postes actifs de John W. Gillard
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de John W. Gillard
Anciens postes connus de John W. Gillard
Sociétés | Poste | Début | Fin |
---|---|---|---|
GLYCODesign, Inc.
![]() GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 01/01/1997 | 01/01/2003 |
Apoptogen, Inc. | President | 01/01/1997 | 01/01/2000 |
Ottawa Life Sciences Council | Directeur/Membre du Conseil | 01/01/1997 | 01/01/2000 |
Kinetek Pharmaceuticals, Inc. | Président | 01/01/1998 | 01/01/1999 |
Canadian Genetics Diseases Network
![]() Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 01/01/1992 | 01/01/1999 |
Biochem Pharma, Inc.
![]() Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Directeur Technique/Scientifique/R&D | 01/01/1991 | 01/01/1996 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1980 | 01/01/1991 |
Nuchem Therapeutics, Inc.
![]() Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - | - |
░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de John W. Gillard
University of Tasmania | Doctorate Degree |
Statistiques
Internationale
Canada | 10 |
Etats-Unis | 3 |
Australie | 2 |
Opérationnelle
Director/Board Member | 6 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 8 |
Commercial Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Entreprise privées | 10 |
---|---|
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
IBEX Technologies, Inc.
![]() IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Molecular Templates, Inc. /Old/
![]() Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Biochem Pharma, Inc.
![]() Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
Apoptogen, Inc. | |
Kinetek Pharmaceuticals, Inc. | Health Technology |
Canadian Genetics Diseases Network
![]() Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Commercial Services |
Ottawa Life Sciences Council | |
GLYCODesign, Inc.
![]() GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Health Technology |
Nuchem Therapeutics, Inc.
![]() Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Commercial Services |
- Bourse
- Insiders
- John W. Gillard
- Expérience